{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T07:32:14Z","timestamp":1692171134609},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,9,13]],"date-time":"2007-09-13T00:00:00Z","timestamp":1189641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s00467-007-0592-1","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T16:37:05Z","timestamp":1189615025000},"page":"1931-1938","source":"Crossref","is-referenced-by-count":2,"title":["Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?"],"prefix":"10.1007","volume":"22","author":[{"given":"Tuure T.","family":"Saarinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Arikoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"R\u00f6nnholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,13]]},"reference":[{"key":"592_CR1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ki.1988.96","volume":"33","author":"IB Salusky","year":"1988","unstructured":"Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975\u2013982","journal-title":"Kidney Int"},{"key":"592_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrad","year":"1993","unstructured":"Sherrad DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder. Kidney Int 43:436\u2013442","journal-title":"Kidney Int"},{"key":"592_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s004670050462","volume":"12","author":"BA Fivush","year":"1998","unstructured":"Fivush BA, Jabs K, Neu AM, Sullivan EK, Feld L, Kohaut E, Fine R (1998) Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. Pediatr Nephrol 12:328\u2013337","journal-title":"Pediatr Nephrol"},{"key":"592_CR4","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1359\/jbmr.1999.14.10.1680","volume":"14","author":"BD Kuizon","year":"1999","unstructured":"Kuizon BD, Salusky IB (1999) Growth retardation in children with chronic renal failure. J Bone Miner Res 14:1680\u20131690","journal-title":"J Bone Miner Res"},{"key":"592_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00858984","volume":"9","author":"C Holmberg","year":"1995","unstructured":"Holmberg C, Antikainen M, R\u00f6nnholm K, Ala-Houhala M, Jalanko H (1995) Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 9:87\u201393","journal-title":"Pediatr Nephrol"},{"key":"592_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s004670050183","volume":"10","author":"IB Salusky","year":"1996","unstructured":"Salusky IB, Goodman WG (1996) The management of renal osteodystrophy. Pediatr Nephrol 10:651\u2013655","journal-title":"Pediatr Nephrol"},{"key":"592_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0002-9629(15)40551-8","volume":"317","author":"TB Drueke","year":"1999","unstructured":"Drueke TB (1999) Medical management of secondary hyperparathyroidism in uremia. Am J Med Sci 317:383\u2013389","journal-title":"Am J Med Sci"},{"key":"592_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000187887","volume":"67","author":"P Herrmann","year":"1994","unstructured":"Herrmann P, Ritz E, Schmidt-Gayk H, Schafer I, Geyer J, Nonnast-Daniel B, Koch KM, Weber U, Hohrl W, Haas-Worle A, K\u00fchn K, Bierther B, Schneider P (1994) Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial. Nephron 67:48\u201353","journal-title":"Nephron"},{"key":"592_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/BF00868726","volume":"9","author":"M Ala-Houhala","year":"1995","unstructured":"Ala-Houhala M, Holmberg C, Ronnholm K, Paganus A, Laine J, Koskimies O (1995) Alphacalcidol oral pulses normalize uremic hyperparathyroidism prior to dialysis. Pediatr Nephrol 9:737\u2013741","journal-title":"Pediatr Nephrol"},{"key":"592_CR10","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/ki.1994.223","volume":"45","author":"LD Quarles","year":"1994","unstructured":"Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA (1994) Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710\u20131721","journal-title":"Kidney Int"},{"key":"592_CR11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1681\/ASN.V73488","volume":"7","author":"BS Levine","year":"1996","unstructured":"Levine BS, Song M (1996) Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol 7:488\u2013496","journal-title":"J Am Soc Nephrol"},{"key":"592_CR12","first-page":"245","volume":"49","author":"V Panichi","year":"1998","unstructured":"Panichi V, Andreini B, DePietro S, Migliori M, Taccola D, Giovannini L, Ferdeghini M, Palla R (1998) Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialysis renal failure. Clin Nephrol 49:245\u2013250","journal-title":"Clin Nephrol"},{"key":"592_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00467-003-1091-7","volume":"18","author":"CP Schmitt","year":"2003","unstructured":"Schmitt CP, Ardissino G, Testa S, Claris-Appiani A, Mehls O, The European Study Group on Vitamin\u00a0D in Children with Chronic Renal Failure (2003) Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18:440\u2013444","journal-title":"Pediatr Nephrol"},{"key":"592_CR14","first-page":"254","volume":"38","author":"M Antikainen","year":"1992","unstructured":"Antikainen M, Holmberg C, Taskinen M-R (1992) Growth, serum lipoproteins and apoproteins in infants with congenital nephrosis. Clin Nephrol 38:254\u2013263","journal-title":"Clin Nephrol"},{"key":"592_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/PL00013417","volume":"14","author":"T H\u00f6ltt\u00e4","year":"2000","unstructured":"H\u00f6ltt\u00e4 T, R\u00f6nnholm K, Jalanko H, Holmberg C (2000) Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control. Pediatr Nephrol 14:889\u2013897","journal-title":"Pediatr Nephrol"},{"key":"592_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ki.1994.380","volume":"46","author":"WG Goodman","year":"1994","unstructured":"Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160\u20131166","journal-title":"Kidney Int"},{"key":"592_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","volume":"53","author":"BD Kuizon","year":"1998","unstructured":"Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205\u2013211","journal-title":"Kidney Int"},{"key":"592_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000057384","volume":"24","author":"BD Kuizon","year":"1998","unstructured":"Kuizon BD, Salusky IB (1998) Intermittent calcitriol therapy and growth in children with chronic renal failure. Miner Electrolyte Metab 24:290\u2013295","journal-title":"Miner Electrolyte Metab"},{"key":"592_CR19","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1093\/ndt\/10.12.2376","volume":"10","author":"A Fournier","year":"1995","unstructured":"Fournier A, Oprisiu R, El Esper N, Moriniere P (1995) Optimal plasma concentrations of intact parathyroid hormone in predialysis patients. Nephrol Dial Transplant 10:2376\u20132378","journal-title":"Nephrol Dial Transplant"},{"key":"592_CR20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1681\/ASN.V86993","volume":"8","author":"AJ Felsenfeld","year":"1997","unstructured":"Felsenfeld AJ (1997) Considerations for the treatment of secondary hyperparathyroidism in renal failure. J Am Soc Nephrol 8:993\u20131004","journal-title":"J Am Soc Nephrol"},{"key":"592_CR21","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00467-003-1284-0","volume":"18","author":"S Waller","year":"2003","unstructured":"Waller S, Ledermann S, Trompeter R, van\u2019t Hoff W, Ridout D, Rees L (2003) Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol 18:1236\u20131241","journal-title":"Pediatr Nephrol"},{"key":"592_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","volume":"26","author":"M Wang","year":"1995","unstructured":"Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y (1995) Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836\u2013844","journal-title":"Am J Kidney Dis"},{"key":"592_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s004670050184","volume":"10","author":"SP Ridgen","year":"1996","unstructured":"Ridgen SP (1996) The treatment of renal osteodystrophy. Pediatr Nephrol 10:653\u2013655","journal-title":"Pediatr Nephrol"},{"key":"592_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A, Fischbach M, R\u00f6nnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schr\u00f6der C, Zurowska A, Ekim M (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151\u2013159","journal-title":"Pediatr Nephrol"},{"key":"592_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s004670050294","volume":"11","author":"F Yal\u00e7\u0131nkaya","year":"1997","unstructured":"Yal\u00e7\u0131nkaya F, T\u00fcmer N, \u00c7akar N, \u00d6zkaya N (1997) Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 11:350\u2013352","journal-title":"Pediatr Nephrol"},{"key":"592_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/ndt\/15.9.1438","volume":"15","author":"T H\u00f6ltt\u00e4","year":"2000","unstructured":"H\u00f6ltt\u00e4 T, R\u00f6nnholm K, Holmberg C (2000) Adequacy of dialysis with tidal and continuous cycling peritoneal dialysis in children. Nephrol Dial Transplant 15:1438\u20131442","journal-title":"Nephrol Dial Transplant"},{"key":"592_CR27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/089686089701700609","volume":"17","author":"T H\u00f6ltt\u00e4","year":"1997","unstructured":"H\u00f6ltt\u00e4 T, R\u00f6nnholm K, Jalanko H, Ala-Houhala M, Antikainen M, Holmberg C (1997) Peritoneal dialysis in children under 5 years of age. Perit Dial Int 17:573\u2013580","journal-title":"Perit Dial Int"},{"key":"592_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/adc.51.5.344","volume":"51","author":"N-P Huttunen","year":"1976","unstructured":"Huttunen N-P (1976) Congenital nephrotic syndrome of the Finnish type. Study of 75 patients. Arch Dis Child 51:344\u2013348","journal-title":"Arch Dis Child"},{"key":"592_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/BF00857558","volume":"7","author":"M Antikainen","year":"1993","unstructured":"Antikainen M (1993) Protein and lipid metabolism in nephrotic infants on peritoneal dialysis after nephrectomy. Pediatr Nephrol 7:428\u2013433","journal-title":"Pediatr Nephrol"},{"key":"592_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s004670000365","volume":"14","author":"G Ardissino","year":"2000","unstructured":"Ardissino G, Schmitt CP, Testa S, Claris-Appiani A, Mehls O for the European Study Group on Vitamin\u00a0D in Children with Renal Failure (2000) Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. Pediatr Nephrol 14:664\u2013668","journal-title":"Pediatr Nephrol"},{"key":"592_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/BF01453682","volume":"5","author":"G Klaus","year":"1991","unstructured":"Klaus G, Meinhold-Heerlein R, Milde P, Ritz E, Mehls O (1991) Effect of vitamin\u00a0D on growth cartilage cell proliferation in vitro. Pediatr Nephrol 5:461\u2013466","journal-title":"Pediatr Nephrol"},{"key":"592_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1681\/ASN.2003100878","volume":"16","author":"CP Sanchez","year":"2005","unstructured":"Sanchez CP, Yu-Zhu H (2005) Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism. J Am Soc Nephrol 16:929\u2013938","journal-title":"J Am Soc Nephrol"},{"key":"592_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1210\/endo-110-2-506","volume":"110","author":"CS Tam","year":"1982","unstructured":"Tam CS, Heersche JNM, Murray TM, Parsons JA (1982) Parathyroid hormone stimulates the bone apposition rate independently of its resorption action: differential effects of intermittent and continuous administration. Endocrinology 110:506\u2013512","journal-title":"Endocrinology"},{"key":"592_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0221-8747(84)90026-2","volume":"5","author":"M Gunness-Hey","year":"1984","unstructured":"Gunness-Hey M, Hock JM (1984) Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis 5:177\u2013180","journal-title":"Metab Bone Dis"},{"key":"592_CR35","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1046\/j.1523-1755.2000.00993.x","volume":"57","author":"CP Schmitt","year":"2000","unstructured":"Schmitt CP, Hessing S, Oh J, Weber L, Ochlich P, Mehls O (2000) Intermittent administration of parathyroid hormone (1\u201337) improves growth and bone mineral density in uremic rats. Kidney Int 57:1484\u20131492","journal-title":"Kidney Int"},{"key":"592_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s004670000346","volume":"14","author":"O Mehls","year":"2000","unstructured":"Mehls O, Kn\u00f6ller N, Oh J, Wesch H, W\u00fcnsche B, Schmitt CP (2000) Daily but not pulse calcitriol therapy improves growth in experimental uremia. Pediatr Nephrol 14:658\u2013663","journal-title":"Pediatr Nephrol"},{"key":"592_CR37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/089686080602600112","volume":"26","author":"M Avila-Diaz","year":"2006","unstructured":"Avila-Diaz M, Matos M, Garcia-Lopez E, Prado MD, Castro-Vazquez F, Ventura MD, Gonzalez E, Amato D, Paniagua R (2006) Serum markers of low turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis. Perit Dial Int 26:78\u201384","journal-title":"Perit Dial Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0592-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-007-0592-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0592-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0592-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T09:10:42Z","timestamp":1629709842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-007-0592-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,13]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1007\/s00467-007-0592-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,13]]}}}